Page last updated: 2024-08-21

aminophylline and ah 21-132

aminophylline has been researched along with ah 21-132 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Iwama, T; Mori, H; Nagai, H; Takeda, H; Yamaguchi, S1
Kitagaki, K; Koda, A; Nagai, H; Tsuruoka, N; Yamaguchi, S1
Kobayashi, J; Kurita, C; Nagai, H; Nagao, T; Nakao, T; Tanaka, H; Usami, E; Watanabe, S; Yamazaki, F; Yoshimura, T1

Other Studies

3 other study(ies) available for aminophylline and ah 21-132

ArticleYear
Studies on anti-allergic action of AH 21-132, a novel isozyme-selective phosphodiesterase inhibitor in airways.
    Japanese journal of pharmacology, 1995, Volume: 67, Issue:2

    Topics: Aminophylline; Animals; Dose-Response Relationship, Drug; Guinea Pigs; Histamine Release; Male; Naphthyridines; Phosphodiesterase Inhibitors; Pulmonary Ventilation; Pyrrolidinones; Rolipram; Time Factors

1995
Priming with murine recombinant interleukin-5 resulted in the augmentation of PAF-induced airway hyperresponsiveness to histamine in guinea pigs.
    Life sciences, 1993, Volume: 52, Issue:17

    Topics: Aminophylline; Animals; Bronchoconstriction; Guinea Pigs; Histamine; Interleukin-5; Leukocyte Count; Male; Naphthyridines; Phosphodiesterase Inhibitors; Platelet Activating Factor; Purinones; Recombinant Proteins

1993
Effects of cAMP-phosphodiesterase isozyme inhibitor on cytokine production by lipopolysaccharide-stimulated human peripheral blood mononuclear cells.
    General pharmacology, 1997, Volume: 29, Issue:4

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Aminophylline; Bucladesine; Cytokines; Humans; In Vitro Techniques; Interleukin-1; Interleukin-8; Isoenzymes; Leukocytes, Mononuclear; Lipopolysaccharides; Milrinone; Naphthyridines; Phosphodiesterase Inhibitors; Purinones; Pyridones; Pyrrolidinones; Rolipram; Terbutaline; Tumor Necrosis Factor-alpha

1997